Daré Bioscience Inc. (DARE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Daré Bioscience Inc.

    NASDAQ: DARE · Real-Time Price · USD
    2.18
    0.03 (1.40%)
    At close: Oct 03, 2025, 3:59 PM
    2.16
    -0.92%
    After-hours: Oct 03, 2025, 05:52 PM EDT

    Daré Bioscience Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.78K 2.81M 10M n/a
    Cost of Revenue
    		 513.33K 38.36K 47.62K 26.41K
    Gross Profit
    		 -503.54K 2.77M 9.95M -26.41K
    Operating Income
    		 -23.45M -30.94M -31.39M -39.07M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -4.05M -30.16M -30.95M -38.7M
    Net Income
    		 -4.05M -30.16M -30.95M -38.33M
    Selling & General & Admin
    		 9.16M 12.11M 11.24M 8.35M
    Research & Development
    		 14.21M 21.54M 30.04M 30.62M
    Other Expenses
    		 -14.21M 100K 100K n/a
    Operating Expenses
    		 9.16M 33.61M 41.38M 39.07M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 800K n/a n/a 561K
    Cost & Expenses
    		 23.46M 33.75M 41.38M 39.07M
    Income Tax Expense
    		 n/a n/a n/a -370K
    Shares Outstanding (Basic)
    		 8.5M 7.28M 7.05M 5.1M
    Shares Outstanding (Diluted)
    		 8.5M 7.28M 7.05M 5.1M
    EPS (Basic)
    		 -0.48 -4.15 -4.39 -7.52
    EPS (Diluted)
    		 -0.48 -4.15 -4.39 -7.52
    EBITDA
    		 -23.41M -30.9M -31.36M -39.04M
    EBIT
    		 -23.45M -30.74M -31.39M -39.07M
    Depreciation & Amortization
    		 42.33K 38.36K 24.2K 26.41K

    Add to Watchlist